| Schedule of Term Loans and Financing Activity |
During the periods covered by this report, the base rates, margins and effective interest rates were as follows for the periods indicated: | | | | | | | | | | Period | Base Rate plus Margin | Effective Rate | | | | As of December 31, 2025 | SOFR plus 2.25% Prime Rate plus 1.25% | 6.07% (credit spread adjustment of 0.00% ) 8.0% | As of March 31, 2026 | SOFR plus 2.25% Prime Rate plus 1.25% | 5.9% (credit spread adjustment of 0.00%) 8.0% |
As of March 31, 2026 and December 31, 2025 our term loan debt and other obligations are as follows (in thousands): | | | | | | | | | | | | | | March 31,
2026 | | December 31,
2025 | | Barclays Term Loans collateralized by RadNet's tangible and intangible assets | $ | 958,680 | | | $ | 961,119 | | | Discount on Barclays Term Loans | (11,199) | | | (11,759) | | | Truist Term Loan Agreement collateralized by NJIN's tangible and intangible assets | 120,937 | | | 123,750 | | | Discount on Truist Term Loan Agreement | (396) | | | (462) | | | | | | Equipment notes payable at 3.6% to 7.2%, due through 2029, collateralized by medical equipment | 15,626 | | | 17,271 | | | Other notes payable, due through 2034 | 2,835 | | | — | | | Total debt obligations | 1,086,483 | | | 1,089,919 | | | Less: current portion | (26,506) | | | (25,424) | | | Long term portion of debt obligations | $ | 1,059,977 | | | $ | 1,064,495 | |
|